Most Popular in:
Sun Care Treatments
Sunscreens for Today’s Clients
By: Rachel Ametsitsi, Ada S. Polla and Anne Pouillot
Posted: January 2, 2014, from the January 2014 issue of Skin Inc. magazine.
page 4 of 5
Overall, what is true in life is true in the realm of sunscreens—the only constant is change. Between innovative ingredients continually developed by cosmetic and pharmaceutical companies, and the ever-shifting guidelines from the FDA, your role as a skin care professional is to continue to educate yourself, and to further educate your clients. In this world of flux, however, two concepts do remain: Sun avoidance is the best anti-aging remedy there is and sun protection is second in line. Because of this, sunscreen should be an essential part of every client’s daily skin care routine.
- K Scharffetter-Kochaneck, P Brenneisen, J Wenk, G Herrmann, W Ma, L Kuhr, C Meewes, M Wlaschek, Photoaging of the skin from phenotype to mechanisms, Exp Gerontol 35 307–316 (2000)
- C Nishigori, Y Hattori, S Toyokuni, Role of reactive oxygen species in skin carcinogenesis, Antiox Redox Signal 6(3) 561–570 (2004)
- O Reelfs, RM Tyrrell, C Pourzand, Ultraviolet A radiation-induced immediate iron release is a key modulator of the activation of NF-kappaB in human skin fibroblasts, J Invest Dermatol 122(6) 1440–1447 (2004)
- A Dupuy, A Dunant A, JJ Grob, Randomized controlled trial testing the impact of high-protection sunscreens on sun-exposure behavior, Arch Dermatol 141 950–956 (2005)
- RM Sayre, N Kollias, RL Roberts, A Baqer, I Sadiq, Physical sunscreens, J Soc Cosmet Chem 41 103–109 (1990)
- EJ Collaris, J Frank, Photoallergic contact dermatitis caused by ultraviolet filters in different sunscreens, Int J Dermatol 47(S1) 35–37 (2008)
- JM Allen, CJ Gossett, SK Allen, Photochemical formation of singlet molecular oxygen in illuminated aqueous solutions of several commercially available sunscreen active ingredients, Chem Res Toxico 9 605–609 (1996)
- JF Nash, Human safety and efficacy of UV filters and sunscreen products, Dermatol Clin 24(1) 35–51 (2006)
- C Szurko, A Dompmartin, M Michel, A Moreau, D Leroy, Photocontact allergy to oxybenzone: ten years of experience, Photodermatol Photimmunol Photomed 10 144–147 (1994)
Rachel Ametsitsi recently joined Alchimie Forever as scientific assistant. With research experience and a master of scientific international business, she works in new product R & D, scientific writing and international business development.
Ada Polla is the president, CEO and co-creator of Alchimie Forever. She was a founding member and is the treasurer of the Washington Spa Alliance; was featured on the cover of Business Week Small Biz; and was a nominee for the Emerging Entrepreneur of the Year award from Entrepreneur magazine.